|
DCI expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.50790000000134E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.019650E-04 |
| Normal-vs-Stage2 |
7.343000E-01 |
| Normal-vs-Stage3 |
2.19589999999048E-05 |
| Normal-vs-Stage4 |
5.883800E-03 |
| Stage1-vs-Stage2 |
2.120800E-01 |
| Stage1-vs-Stage3 |
2.902600E-01 |
| Stage1-vs-Stage4 |
8.510600E-01 |
| Stage2-vs-Stage3 |
1.027960E-01 |
| Stage2-vs-Stage4 |
2.176400E-01 |
| Stage3-vs-Stage4 |
5.908600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.55463999998995E-05 |
| Normal-vs-AfricanAmerican |
7.761000E-01 |
| Normal-vs-Asian |
4.789600E-01 |
| Caucasian-vs-AfricanAmerican |
1.281510E-02 |
| Caucasian-vs-Asian |
8.544000E-01 |
| AfricanAmerican-vs-Asian |
4.559400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.00289999999315E-06 |
| Normal-vs-Female |
2.591800E-02 |
| Male-vs-Female |
2.394000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.166400E-04 |
| Normal-vs-Age(41-60Yrs) |
2.3257999999915E-05 |
| Normal-vs-Age(61-80Yrs) |
4.397100E-04 |
| Normal-vs-Age(81-100Yrs) |
6.358800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.815200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.351200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.035190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.391200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.583220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.169000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.700000E-02 |
| Normal-vs-Grade 2 |
1.256640E-03 |
| Normal-vs-Grade 3 |
4.433900E-04 |
| Normal-vs-Grade 4 |
5.72509999999804E-05 |
| Grade 1-vs-Grade 2 |
7.685600E-01 |
| Grade 1-vs-Grade 3 |
8.790200E-01 |
| Grade 1-vs-Grade 4 |
3.344800E-01 |
| Grade 2-vs-Grade 3 |
8.595600E-01 |
| Grade 2-vs-Grade 4 |
6.494400E-02 |
| Grade 3-vs-Grade 4 |
5.992200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.304600E-03 |
| Normal-vs-ccB subtype |
2.52849963189306E-10 |
| ccA subtype-vs-ccB subtype |
2.59170000005415E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.000710E-04 |
| Normal-vs-N1 |
1.461410E-01 |
| N0-vs-N1 |
7.187200E-01 |
|
|
